GENOCEA BIOSCIENCES INC (GNCA) Stock Analyst Ratings
NASDAQ:GNCA - Nasdaq - US3724274010 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to GNCA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.14. This target is 6060% above the current price.
GNCA was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about GNCA.
In the previous month the buy percentage consensus was at a similar level.
GNCA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-04-29 | Stifel | Downgrade | Buy -> Hold |
| 2022-04-29 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2021-04-06 | SVB Leerink | Maintains | Outperform |
| 2021-02-11 | Needham | Maintains | Buy |